Gynoviva

Gynoviva is an over‑the‑counter vaginal probiotic that contains the bacterial strains Lactobacillus gasseri DSM 14869 and Lactobacillus rhamnosus DSM 14870. The product is formulated to be applied intravaginally and is marketed in the European Union. It belongs to the probiotic drug class and is intended to support the normal balance of vaginal microbiota without a specified strength or dosage form listed or specific concentration for use.

Gynoviva is used to help maintain a healthy vaginal ecosystem, particularly in situations where the natural balance may be disrupted.

- Supports restoration of normal Lactobacillus-dominated flora after antibiotic therapy. - May aid in reducing the recurrence of bacterial vaginosis symptoms. - Intended for use in women experiencing mild vaginal discomfort or odor linked to dysbiosis. - Can be part of a routine vaginal health regimen for women of reproductive age. - May complement standard hygiene practices to promote genitourinary comfort.

Reported adverse events with vaginal probiotics are generally mild, but rare serious reactions have been described.

Common: - Temporary vaginal irritation or itching. - Mild discharge with a slight odor. - Slight burning sensation during application. - Transient increase in vaginal moisture.

Serious: - Allergic reaction such as swelling, rash, or hives. - Severe pelvic pain or fever indicating possible infection. - Persistent abnormal discharge requiring medical evaluation.

Before using Gynoviva, consider the following safety information to ensure appropriate use.

- Do not use if you have a known hypersensitivity to any Lactobacillus strains. - Avoid application during active vaginal infections without prior medical assessment. - Consult a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding. - Keep the product out of reach of children and store according to label instructions. - Discontinue use and seek medical advice if symptoms worsen or persist. - Do not use beyond the recommended period indicated on the packaging.

Vaginal probiotics have limited systemic interactions, but certain products may affect their efficacy.

Avoid: - Concurrent use of intravaginal antiseptics or douches that may destroy probiotic bacteria. - Antibiotic vaginal suppositories administered at the same time as the probiotic. - Antifungal treatments applied intravaginally that could alter the microbial environment.

Use with caution: - Systemic antibiotics taken orally, which may reduce overall Lactobacillus populations. - Hormonal contraceptives that influence vaginal pH. - Other probiotic products; consider spacing applications to avoid competition.